Neovasc Inc. buy marge
Start price
16.10.18
/
50%
€563.75
Target price
16.04.19
€902.00
Performance (%)
-83.00%
End price
16.04.19
€95.84
Summary
This prediction ended on 16.04.19 with a price of €95.84. The BUY prediction by marge for Neovasc Inc. performed very badly with a performance of -83.00%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neovasc Inc. | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by marge for this prediction
In the thread Neovasc Inc diskutieren
marge stimmt der Buy-Einschätzung von Thorsten_78 zu
10.10.2018 Neovasc announces that the FDA has granted Breakthrough Device designation to the Neovasc Reducer, a medical device for the treatment of refractory angina, which is not currently approved for commercial sale in the U.S.
(Laufzeit überschritten)